4.7 Article

TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Mechanisms of Regulation and Diverse Activities of Tau-Tubulin Kinase (TTBK) Isoforms

Channa Bao et al.

Summary: TTBK1 is a CNS-specific kinase involved in tau phosphorylation, particularly at Serine 422, associated with tauopathies like AD and FTD. Despite structural similarity with TTBK1, TTBK2's enzymatic activity is differently regulated by non-catalytic sequences and autophosphorylation events. Identification of neuronal interactors and phosphorylation substrates for TTBK1 and TTBK2 sheds light on their unique cellular pathways and networks, providing insight for potential therapeutic development.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2021)

Review Pharmacology & Pharmacy

Protein kinase inhibitors for amyotrophic lateral sclerosis therapy

Valle Palomo et al.

Summary: ALS is a fatal neurodegenerative disorder with no effective treatment currently available. Multiple pathological mechanisms such as abnormal protein aggregation, neuroinflammation and dysregulation of the ubiquitin proteasome system are involved in the neuropathology of this disease. The lack of reliable animal models has hindered drug development for ALS.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Chemistry, Medicinal

Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral

Elisa Rojas-Prats et al.

Summary: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with proteinopathy involving TDP-43 aggregates. The discovery of a new family of selective CDC7 inhibitors that can reduce TDP-43 phosphorylation suggests potential for future ALS therapies.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In Vivo

Tamara Halkina et al.

Summary: Structural analysis of the known NIK inhibitor 3 bound to the kinase domain of TTBK1 led to the design and synthesis of a novel class of azaindazole TTBK1 inhibitors exemplified by 8. Optimization of this series of analogs resulted in the discovery of 31, a potent and selective TTBK inhibitor with suitable CNS penetration for in vivo pharmacology studies. The ability of 31 to inhibit tau phosphorylation at the disease-relevant Ser 422 epitope was demonstrated in animal models, suggesting its potential relevance in the treatment of Alzheimer's disease and other tauopathies.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis

Loreto Martinez-Gonzalez et al.

Summary: The study suggests that GSK-3 beta activity is related to ALS and Tideglusib may be a promising therapeutic drug for ALS, effectively reducing TDP-43 phosphorylation levels.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biotechnology & Applied Microbiology

Trends in kinase drug discovery: targets, indications and inhibitor design

Misty M. Attwood et al.

Summary: The article analyzes the landscape of approved and investigational therapies that target kinases, highlighting the increasing importance of kinase inhibitors in oncology and beyond. It discusses trends in kinase inhibitor design and points out that there are still substantial unexplored opportunities for this drug class.

NATURE REVIEWS DRUG DISCOVERY (2021)

Review Clinical Neurology

TDP-43 proteinopathies: a new wave of neurodegenerative diseases

Eva Maria Johanna de Boer et al.

Summary: TDP-43 is a crucial protein involved in the pathogenesis of various neurodegenerative diseases, including ALS and FTLD. Understanding the molecular pathways through which TDP-43 mediates neurodegeneration is essential for the development of effective therapies.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Article Biochemical Research Methods

The crystal structure of the catalytic domain of tau tubulin kinase 2 in complex with a small-molecule inhibitor

Douglas J. Marcotte et al.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment

Loreto Martinez-Gonzalez et al.

SCIENTIFIC REPORTS (2020)

Review Neurosciences

The role of TDP-43 mislocalization in amyotrophic lateral sclerosis

Terry R. Suk et al.

MOLECULAR NEURODEGENERATION (2020)

Article Chemistry, Physical

OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules

Katarina Roos et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2019)

Review Biochemistry & Molecular Biology

Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Henriette Haukedal et al.

JOURNAL OF MOLECULAR BIOLOGY (2019)

Review Neurosciences

Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis

Archana Prasad et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)

Review Biochemistry & Molecular Biology

Tau tubulin kinases in proteinopathy

Laura M. Taylors et al.

FEBS JOURNAL (2019)

Review Chemistry, Medicinal

Tau Tubulin Kinase 1 (TTBK1), a new player in the fight against neurodegenerative diseases

Vanesa Nozal et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Biochemistry & Molecular Biology

TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral Sclerosis

Valle Palomo et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Article Neurosciences

TDP43 and RNA instability in amyotrophic lateral sclerosis

Kaitlin Weskamp et al.

BRAIN RESEARCH (2018)

Article Biochemistry & Molecular Biology

Heat Shock-induced Phosphorylation of TAR DNA-binding Protein 43 (TDP-43) by MAPK/ERK Kinase Regulates TDP-43 Function

Wen Li et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Review Neurosciences

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

Yu Tang et al.

MOLECULAR NEUROBIOLOGY (2016)

Review Clinical Neurology

TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets

Emma L. Scotter et al.

NEUROTHERAPEUTICS (2015)

Article Chemistry, Applied

Lewis Acid-Catalyzed Generation of C-C and C-N Bonds on π-Deficient Heterocyclic Substrates

Matteo Staderini et al.

ADVANCED SYNTHESIS & CATALYSIS (2015)

Article Clinical Neurology

The El Escorial criteria: Strengths and weaknesses

Federica Agosta et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2015)

Article Multidisciplinary Sciences

Cep164 triggers ciliogenesis by recruiting Tau tubulin kinase 2 to the mother centriole

Lukas Cajanek et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Genetics & Heredity

The Tau Tubulin Kinases TTBK1/2 Promote Accumulation of Pathological TDP-43

Nicole F. Liachko et al.

PLOS GENETICS (2014)

Article Biochemical Research Methods

The structure of human tau-tubulin kinase 1 both in the apo form and in complex with an inhibitor

Susan E. Kiefer et al.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2014)

Article Biochemical Research Methods

How good are my data and what is the resolution?

Philip R. Evans et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2013)

Article Clinical Neurology

CDC7 Inhibition Blocks Pathological TDP-43 Phosphorylation and Neurodegeneration

Nicole F. Liachko et al.

ANNALS OF NEUROLOGY (2013)

Article Biochemistry & Molecular Biology

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

G. Madhavi Sastry et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)

Editorial Material Biochemistry & Molecular Biology

TTBK2 Kinase: Linking Primary Cilia and Cerebellar Ataxias

Peter K. Jackson

Article Biochemical Research Methods

Integration, scaling, space-group assignment and post-refinement

Wolfgang Kabsch

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Chemistry, Medicinal

Analysis of Kinase Inhibitor Selectivity using a Thermodynamics-Based Partition Index

Alan C. Cheng et al.

JOURNAL OF MEDICINAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

Identification of casein kinase-1 phosphorylation sites on TDP-43

Fuyuki Kametani et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)

Article Multidisciplinary Sciences

TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration

Iga Wegorzewska et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Biochemistry & Molecular Biology

The selectivity of protein kinase inhibitors: a further update

Jenny Bain et al.

BIOCHEMICAL JOURNAL (2007)

Article Chemistry, Multidisciplinary

Phaser crystallographic software

Airlie J. McCoy et al.

JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)

Article Chemistry, Medicinal

Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes

Richard A. Friesner et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

Article Biochemistry & Molecular Biology

Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation

Shinji Sato et al.

JOURNAL OF NEUROCHEMISTRY (2006)

Article Chemistry, Medicinal

Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

RA Friesner et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)

Article Chemistry, Medicinal

Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening

TA Halgren et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)

Article Biochemical Research Methods

Coot:: model-building tools for molecular graphics

P Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)

Article Chemistry, Medicinal

High throughput artificial membrane permeability assay for blood-brain barrier

L Di et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)